The cost of a state supported anti-retroviral programme in its most expensive year could be below R10-billion and still be highly effective, according to calculations by Treatment Action Campaign (TAC) and researchers at the University of Cape Town (UCT). TAC manager, Nathan Geffen, presented these figures to Parliament’s Portfolio Committee on Health last week.